{{italic title}} 
 {{Taxobox 
 | name = ''Streptomyces'' 
 | image = Streptomyces griseus color enhanced scanning electron micrograph..jpg 
 | image_width = 240px 
 | image_caption = ''S. griseus'' - a species of ''Streptomyces'' genus 
 | regnum = [[Bacteria]] 
 | phylum = [[Actinomycetota]] 
 | classis = [[Actinomycetia]] 
 | ordo = [[Streptomycetales]] 
 | familia = [[Streptomycetaceae]] 
 | genus = '''''Streptomyces''''' 
 | genus_authority = Waksman  & amp; Henrici 1943 
 }} 
 
 '''''Streptomyces''''' is the largest [[genus]] of [[Actinobacteria]], [[Gram-positive]] bacteria. < ref name= " Kämpfer " > {{cite book |author=Kämpfer P. |chapter=The Family Streptomycetaceae, Part I: Taxonomy |title=The prokaryotes: a handbook on the biology of bacteria |editor=Dworkin M. | display-authors = etal |publisher=Springer |location=Berlin |year=2006 |pages=538–604 |isbn=0-387-25493-5}} < /ref >  ''Streptomyces'' is often found in [[soil]] and is very much similar to [[Fungus|fungi]] by its shape. They form long thin threads called [[Mycelium|hyphae]] that can differentiate into a chain of [[spore]]s for [[reproduction]]. < ref > {{Cite journal|last1=de Lima Procópio|first1=Rudi Emerson|last2=da Silva|first2=Ingrid Reis|last3=Martins|first3=Mayra Kassawara|last4=de Azevedo|first4=João Lúcio|last5=de Araújo|first5=Janete Magali|date=2012-09-01|title=Antibiotics produced by Streptomyces|url=https://www.sciencedirect.com/science/article/pii/S1413867012001341|journal=The Brazilian Journal of Infectious Diseases|language=en|volume=16|issue=5|pages=466–471|doi=10.1016/j.bjid.2012.08.014|pmid=22975171 |issn=1413-8670}} < /ref >  Almost all of the bioactive compounds produced by ''Streptomyces'' are made while the hyphae are forming from the substrate [[mycelium]]. < ref name= " Chater " > Chater, Keith F. ''et al'' 2010. The complex extracellular biology of Streptomyces. ''FEMS Microbiology Reviews'' '''34''' (2): 171–98. [http://onlinelibrary.wiley.com/doi/10.1111/j.1574-6976.2009.00206.x/abstract;jsessionid=16BF7D1C9CC37A85CC34C60EF1923355.f01t03] < /ref > 
 
 == Use in medicine and science == 
 Streptomyces are medically important, as they produce antifungals, antiparasitic drugs, [[Antiviral drug|antivirals]], antitumorals, anti-hypertensives, [[Immunosuppressant drugs|immunosuppressants]] and [[antibiotics]]. < ref > {{Cite journal|last1=Ōmura|first1=Satoshi|last2=Ikeda|first2=Haruo|last3=Ishikawa|first3=Jun|last4=Hanamoto|first4=Akiharu|last5=Takahashi|first5=Chigusa|last6=Shinose|first6=Mayumi|last7=Takahashi|first7=Yoko|last8=Horikawa|first8=Hiroshi|last9=Nakazawa|first9=Hidekazu|last10=Osonoe|first10=Tomomi|last11=Kikuchi|first11=Hisashi|date=2001-10-09|title=Genome sequence of an industrial microorganism Streptomyces avermitilis : Deducing the ability of producing secondary metabolites|journal=Proceedings of the National Academy of Sciences|language=en|volume=98|issue=21|pages=12215–12220|doi=10.1073/pnas.211433198|issn=0027-8424|pmc=59794|pmid=11572948|doi-access=free }} < /ref > < ref name= " pmid11702082 " > {{cite journal|author=Watve M.G.|display-authors=etal|year=2001|title=How many antibiotics are produced by the genus Streptomyces?|url=|journal=Arch. Microbiol.|volume=176|issue=5|pages=386–90|doi=10.1007/s002030100345|pmid=11702082|s2cid=603765}} < /ref >  Different species of streptomyces are used to produce different antibiotics. Over 500 species of ''Streptomyces'' [[bacteria]] have been described. < ref > {{cite web|author=Euzéby J.P.|year=2008|title=Genus Streptomyces|url=http://www.bacterio.cict.fr/s/streptomycesa.html|url-status=dead|archive-url=https://web.archive.org/web/20121225223831/http://www.bacterio.cict.fr/s/streptomycesa.html|archive-date=2012-12-25|work=List of prokaryotic names with standing in nomenclature|accessdate=2008-09-28}} < /ref >  For example, widely studied ''S. griseus'' was the first to be used in production of an antibiotic [[streptomycin]], while ''S. avermitilis'' as a source of [[avermictin]]. < ref > {{Cite journal|last1=Ohnishi|first1=Yasuo|last2=Ishikawa|first2=Jun|last3=Hara|first3=Hirofumi|last4=Suzuki|first4=Hirokazu|last5=Ikenoya|first5=Miwa|last6=Ikeda|first6=Haruo|last7=Yamashita|first7=Atsushi|last8=Hattori|first8=Masahira|last9=Horinouchi|first9=Sueharu|date=June 2008|title=Genome Sequence of the Streptomycin-Producing Microorganism Streptomyces griseus IFO 13350|journal=Journal of Bacteriology|language=en|volume=190|issue=11|pages=4050–4060|doi=10.1128/JB.00204-08|issn=0021-9193|pmc=2395044|pmid=18375553}} < /ref >  Another well-studied species, ''S coelicolor'', is widely used in [[Genetics|genetic studies]]. < ref > {{Cite journal|last1=Bentley|first1=S. D.|last2=Chater|first2=K. F.|last3=Cerdeño-Tárraga|first3=A.-M.|last4=Challis|first4=G. L.|last5=Thomson|first5=N. R.|last6=James|first6=K. D.|last7=Harris|first7=D. E.|last8=Quail|first8=M. A.|last9=Kieser|first9=H.|last10=Harper|first10=D.|last11=Bateman|first11=A.|date=May 2002|title=Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)|url=https://www.nature.com/articles/417141a|journal=Nature|language=en|volume=417|issue=6885|pages=141–147|doi=10.1038/417141a|pmid=12000953 |s2cid=4430218 |issn=1476-4687}} < /ref >  Overall, Streptomyces produce over two-thirds of the clinically useful antibiotics of natural origin, such as [[tetracycline]], [[neomycin]] and [[chloramphenicol]]. < ref > {{Cite journal|last1=Watve|first1=Milind G.|last2=Tickoo|first2=Rashmi|last3=Jog|first3=Maithili M.|last4=Bhole|first4=Bhalachandra D.|date=2001-11-01|title=How many antibiotics are produced by the genus Streptomyces?|url=https://doi.org/10.1007/s002030100345|journal=Archives of Microbiology|language=en|volume=176|issue=5|pages=386–390|doi=10.1007/s002030100345|pmid=11702082 |s2cid=603765 |issn=1432-072X}} < /ref > < ref > {{cite book|title=Practical Streptomyces genetics|author=Kieser T.|publisher=John Innes Foundation|year=2000|isbn=0-7084-0623-8|edition=2nd|location=Norwich, England|pages=|display-authors=etal}} < /ref > 
 [[File:Streptomyces sp 01.png|thumb|Slide culture of a ''Streptomyces'' species]] 
 
 == Antibiotic mechanism == 
 [[Antibiotics]] target essential [[protein]]s for [[Pathogen|pathogens’]] growth and survival, inhibiting essential functions. For example, [[streptomycin]], which is made from ''S. griseus,'' irreversibly binds to bacterial [[Gene|genetic materia]] < nowiki/ > l and causes errors in the production of new proteins, which leads to cell death. < ref > {{Cite web|last=PubChem|title=Streptomycin|url=https://pubchem.ncbi.nlm.nih.gov/compound/19649|access-date=2022-07-24|website=pubchem.ncbi.nlm.nih.gov|language=en}} < /ref >  It can be used for treating severe [[infection]]s, such as [[tuberculosis]] and [[Bubonic plague|plague]]. < ref > {{Cite web|title=Streptomycin Monograph for Professionals|url=https://www.drugs.com/monograph/streptomycin.html|access-date=2022-07-24|website=Drugs.com|language=en}} < /ref >  Another example is [[avermectin]], made from ''S. avermitili.'' It causes invertebrate [[paralysis]] (inability to make and pass [[nerve impulse]]s), which is used as a [[drug]] and [[pesticide]] against [[parasitic worms]] and [[insect]]s. Avermectin enhances glutamate ([[neurotransmitter]]) at the glutamate-gated chloride channels that [[mammal]]s don’t possess. It causes the excess of [[chloride]] ions inside the cell (hyperpolarisation), so the action potential cannot be further induced, ultimately leading to paralysis. < ref > {{Cite journal|last=Bloomquist|first=Jeffrey R.|date=1993-10-01|title=Toxicology, mode of action and target site-mediated resistance to insecticides acting on chloride channels|url=https://dx.doi.org/10.1016/0742-8413%2893%2990138-B|journal=Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology|language=en|volume=106|issue=2|pages=301–314|doi=10.1016/0742-8413(93)90138-B|pmid=7904908 |issn=0742-8413}} < /ref > 
 
 == Antibiotic resistance == 
 Genetic changes in bacteria might result in [[antibiotic resistance]]. They might be acquired through spontaneous [[mutation]]s ([[vertical gene transfer]]) or through other bacteria passing their genes ([[horizontal gene transfer]]). Self-medications or improper [[medication]] use can result in the emergence of resistant bacteria. It is difficult to obtain new antibiotics, that is why researchers seek to improve existing ones, < ref > {{Cite journal|last1=Fischbach|first1=Michael A.|last2=Walsh|first2=Christopher T.|date=2009-08-28|title=Antibiotics for Emerging Pathogens|journal=Science|language=en|volume=325|issue=5944|pages=1089–1093|doi=10.1126/science.1176667|issn=0036-8075|pmc=2802854|pmid=19713519}} < /ref >  as well as working to discover new drugs. 
 
 == References == 
 {{reflist}} 
 
 [[Category:Gram-positive bacteria]]